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intermediate-to-large lymphocytes with vesicular nuclei, nuclear irregularities, occasional distinct nucleoli and scant cytoplasm. The mitotic rate was brisk. The stroma showed sclerosis and vascular proliferation. Immunoperoxidase stains revealed that the neoplastic cells were weakly positive for leukocyte common antigen (CD45), strongly positive for B-cell markers (CD20, PAX5, CD79a, MUM-1+ and BCL-6+) and negative for T-cell markers (CD3 and CD5). They were also negative for BCL-2, CD10, cyclin D1, CD138, CD34, ALK-1 and CD30. Additionally, they were negative for carcinoma, neuroendocrine and neural markers. The findings were thus consistent with a diffuse large B-cell lymphoma (Fig. 4, 5) .
The patient underwent chemotherapy and radiation therapy but he expired within several months after diagnosis. 
